Victrex plc (LON:VCT) Insider Acquires £958 in Stock

Victrex plc (LON:VCT) insider Urmi Prasad Richardson bought 100 shares of the business’s stock in a transaction dated Friday, March 21st. The stock was acquired at an average cost of GBX 958 ($12.40) per share, for a total transaction of £958 ($1,240.29).

Victrex Stock Performance

Shares of LON:VCT opened at GBX 930 ($12.04) on Wednesday. The business’s 50-day simple moving average is GBX 978 and its 200 day simple moving average is GBX 965.34. The company has a market cap of £811.26 million, a P/E ratio of 26.42, a PEG ratio of 1.92 and a beta of 0.69. The company has a debt-to-equity ratio of 10.93, a quick ratio of 1.99 and a current ratio of 4.39. Victrex plc has a one year low of GBX 816 ($10.56) and a one year high of GBX 1,368 ($17.71).

Victrex (LON:VCT) last posted its quarterly earnings data on Tuesday, December 24th. The company reported GBX 51.70 ($0.67) earnings per share (EPS) for the quarter. Victrex had a net margin of 10.81% and a return on equity of 6.67%. On average, sell-side analysts forecast that Victrex plc will post 73.1078905 earnings per share for the current fiscal year.

Victrex Increases Dividend

The company also recently declared a dividend, which was paid on Friday, February 21st. Investors of record on Thursday, January 23rd were paid a dividend of GBX 46.14 ($0.60) per share. This is an increase from Victrex’s previous dividend of $13.42. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a yield of 5.26%. Victrex’s payout ratio is 170.47%.

Analyst Ratings Changes

Separately, Berenberg Bank lowered their price target on Victrex from GBX 1,290 ($16.70) to GBX 1,170 ($15.15) and set a “hold” rating for the company in a report on Wednesday, December 4th.

Victrex Company Profile

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.